Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Get the latest updates from Roche Media News directly as they happen.
Follow now 321 followers
Last updated 1 day ago
1 day ago
Basel, 30 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
3 days ago
New dengue antigen test delivers high clinical sensitivity and specificity, as well...
4 days ago
Gazyva/Gazyvaro versus mycophenolate mofetil shows significantly more children and young adults achieved...
9 days ago
Basel, 23 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
9 days ago
Basel, 23 October 2025 Group sales grew by 7%1 at constant exchange...
12 days ago
Tecentriq reduced the risk of death by 41% and the risk of...
12 days ago
FDA approval based on superiority of Gazyva/Gazyvaro over standard therapy alone, as...
14 days ago
Giredestrant plus everolimus reduced the risk of disease progression or death by...
14 days ago
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving...
14 days ago
Positive recommendation based on phase II NOBILITY and phase III REGENCY data...
16 days ago
Significant progress in bulk RNA sequencing, methylation mapping, multiomics integration, and spatial...
19 days ago
Basel, 13 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...